浏览全部资源
扫码关注微信
1.陕西中医药大学 第一临床医学院,陕西 咸阳 712046
2.陕西省中医医院,西安 710003
Published:20 December 2021,
Published Online:28 October 2021,
Received:03 July 2021,
扫 描 看 全 文
孙倩,李姗姗,杨少宁等.中医药调控Notch信号通路防治肾脏疾病研究进展[J].中国实验方剂学杂志,2021,27(24):227-234.
SUN Qian,LI Shan-shan,YANG Shao-ning,et al.Traditional Chinese Medicine Regulates Notch Signaling Pathway to Prevent and Treat Renal Diseases:A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(24):227-234.
孙倩,李姗姗,杨少宁等.中医药调控Notch信号通路防治肾脏疾病研究进展[J].中国实验方剂学杂志,2021,27(24):227-234. DOI: 10.13422/j.cnki.syfjx.20212492.
SUN Qian,LI Shan-shan,YANG Shao-ning,et al.Traditional Chinese Medicine Regulates Notch Signaling Pathway to Prevent and Treat Renal Diseases:A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(24):227-234. DOI: 10.13422/j.cnki.syfjx.20212492.
肾脏疾病是临床常见病、多发病,是指各种原因导致的肾脏结构和功能的破坏,可分为原发性、继发性及遗传性肾脏疾病。临床上,肾脏结构和功能的损害通常是一个慢性进展性过程,其导致的慢性肾脏病已成为全世界危害人类健康的重大公共卫生问题。Notch信号通路可影响细胞的增殖、分化、迁移、生长和凋亡等过程,决定细胞的命运,Notch的异常表达或基因突变会引起组织损伤导致各种肾脏疾病的发生和发展。中医药作为防治肾脏疾病的重要手段,具有多种成分作用于多个靶点和多条信号通路的特点,常被用作慢性肾脏病治疗的常规或潜在的补充疗法和丰富的新药发现来源。近年来,因西医治疗对肾脏疾病的局限性,越来越多的学者开始在中医药防治肾脏疾病领域中以Notch信号通路为切入点,进行对各种单味中药或其提取物、中成药及中药复方调控Notch信号通路的临床和实验性研究,并观测到中医药通过抑制Notch信号通路而发挥肾脏保护作用。文章通过收集中医药防治各种肾脏疾病的相关文献,重点对通过调控Notch信号通路发挥防治糖尿病肾病,免疫球蛋白A(IgA)肾病,肾纤维化,膜性肾病,局灶节段性肾小球硬化,肾细胞癌等慢性肾脏病作用的研究文献进行梳理,分析并总结目前研究现状,以期为临床防治各种肾脏疾病提供参考意见,同时为中医药的普遍运用增加事实依据。
As common and frequently-occurring disorders in clinic practice,renal diseases are characterized by the impairment of kidney structure and function due to a variety of reasons and can be divided into primary,secondary, and hereditary types. Clinically,the impairment of kidney structure and function is usually a chronic progressive process,and the resulting chronic renal diseases have become a major public health problem endangering human health worldwide. Notch signaling pathway affects cell proliferation,differentiation,migration,growth, and apoptosis and determines the fate of cells. Abnormal expression or gene mutation of Notch will cause tissue damage, followed by the occurrence and development of a variety of renal diseases. Traditional Chinese medicine (TCM), as an important means to prevent and treat renal diseases,has the characteristics of acting on multiple targets and signaling pathways with multiple components,and is often used as a routine or potential complementary therapy for the treatment of chronic renal diseases and also a source of new drug discovery. In recent years, considering the limitations of western medicine in treating renal diseases,more and more scholars have begun to take Notch signaling pathway as the breakthrough point for exploring TCM prevention and treatment of renal diseases. They have conducted clinical and experimental studies on the regulation of Notch signaling pathway by a variety of individual Chinese herbs or their extracts,Chinese patent medicines, and Chinese medicinal compounds,and found that TCM exerted the renal protective effects by inhibiting the Notch signaling pathway. By collecting relevant literatures on TCM prevention and treatment of various renal diseases,especially those concerning TCM regulation of Notch signaling pathway for preventing and treating such chronic renal diseases as diabetic nephropathy,immunoglobulin A (IgA) nephropathy,renal fibrosis,membranous nephropathy,focal segmental glomerulosclerosis, and renal cell carcinoma,this paper summarized the current research status,in order to provide reference for clinical prevention and treatment of various renal diseases and build up the factual basis for the universal application of TCM.
肾脏疾病Notch中医药糖尿病肾病免疫球蛋白A(IgA)肾病肾纤维化综述
renal diseasesNotchtraditional Chinese medicine (TCM)diabetic nephropathyimmunoglobulin A (IgA) nephropathyrenal fibrosisreview
ZHANG R,JIANG J,YU Y,et al. Analysis of structural components of decellularized scaffolds in renal fibrosis[J]. Bioact Mater,2021,6(7):2187-2197.
JAMTHIKAR A D,PUVVULA A,GUPTA D,et al. Cardiovascular disease and stroke risk assessment in patients with chronic kidney disease using integration of estimated glomerular filtration rate,ultrasonic image phenotypes,and artificial intelligence:a narrative review[J]. Inter Angiol,2021,40(2):150-164.
LV J C,ZHANG L X. Prevalence and disease burden of chronic kidney disease[J]. Adv Exp Med Biol,2019,1165:3-15.
STEVENS P E,LEVIN A. Evaluation and management of chronic kidney disease:synopsis of the kidney disease:improving global outcomes 2012 clinical practice guideline[J]. Ann Intern Med,2013,158(11):825-830.
李平,谢院生,吕继成,等.中成药治疗慢性肾脏病3~5期(非透析)临床应用指南(2020年)[J].中国中西医结合杂志,2021,41(3):261-272.
CHEN D Q,HU H H,WANG Y N,et al. Natural products for the prevention and treatment of kidney disease[J]. Phytomedicine,2018,50:50-60.
WANG M,CHEN L,LIU D,et al. Metabolomics highlights pharmacological bioactivity and biochemical mechanism of traditional Chinese medicine[J]. Chem Biol Interact,2017,273:133-141.
张洁,韩丽红,王彩丽.Notch信号通路在IgA肾病中的表达[J].当代医学,2019,25(29):1-5.
李婷,于青.Notch信号通路在肾脏发育和肾脏疾病的机制研究进展[J].国际泌尿系统杂志,2014,34(4):589-592.
CASTRO R C,GONCALES R A,ZAMBUZI F A,et al. Notch signaling pathway in infectious diseases:role in the regulation of immune response[J]. Inflamm Res,2021,70(3):261-274.
黄仁发,吴金玉,周巧玲.Notch信号通路与肾脏疾病[J].医学综述,2013,19(22):4038-4041.
ARTAVANIS-TSAKONAS S,RAND M D,LAKE R J. Notch signaling:cell fate control and signal integration in development[J]. Science,1999,284(5415):770-776.
何攀,邵凤民.Notch信号通路与肾脏疾病[J].医药论坛杂志,2014,35(1):136-138.
GHAFOURI-FARD S,GLASSY M C,ABAK A,et al. The interaction between miRNAs/lncRNAs and Notch pathway in human disorders[J]. Biomed Pharmacother,2021,138:111496.
SIEBEL C,LENDAHL U. Notch signaling in development,tissue homeostasis,and disease[J]. Physiol Rev,2017,97(4):1235-1294.
MARQUEZ-EXPOSITO L,CANTERO-NAVARRO E,LAVOZ C,et al. Could Notch signaling pathway be a potential therapeutic option in renal diseases?[J]. Nefrologia (Engl Ed),2018,38(5):466-475.
MCCRIGHT B. Notch signaling in kidney development[J]. Curr Opin Nephrol Hypertens,2003,12(1):5-10.
FUJIMURA S,JIANG Q,KOBAYASHI C,et al. Notch2 activation in the embryonic kidney depletes nephron progenitors[J]. J Am Soc Nephrol,2010,21(5):803-810.
SIRIN Y,SUSZTAK K. Notch in the kidney:development and disease[J]. J Pathol,2012,226(2):394-403.
MUREA M,PARK J K,SHARMA S,et al. Expression of Notch pathway proteins correlates with albuminuria,glomerulosclerosis,and renal function[J]. Kidney Int,2010,78(5):514-522.
YUAN C,NI L,ZHANG C,et al. The role of Notch3 signaling in kidney disease[J]. Oxid Med Cell Longev,2020,doi:10.1155/2020/1809408http://dx.doi.org/10.1155/2020/1809408.
CUMMINS T D,MENDENHALL M D,LOWRY M N,et al. Elongin C is a mediator of Notch4 activity in human renal tubule cells[J]. Biochim Biophys Acta,2011,1814(12):1748-1757.
JING Z,HU L,SU Y,et al. Potential signaling pathway through which Notch regulates oxidative damage and apoptosis in renal tubular epithelial cells induced by high glucose[J]. J Recept Signal Transduct Res,2021,41(4):357-362.
高峰,刘淑霞,赵玉峰,等.Notch信号通路在糖尿病小鼠肾组织的表达及意义[J].中国组织化学与细胞化学杂志,2014,23(5):445-449.
BONEGIO R,SUSZTAK K. Notch signaling in diabetic nephropathy[J]. Exp Cell Res,2012,318(9):986-992.
TUNG C,HSU Y,SHIH Y,et al. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy[J]. Nephrology (Carlton),2018,23(Suppl 4):32-37.
LIU L,GAO C,CHEN G,et al. Notch signaling molecules activate TGF-beta in rat mesangial cells under high glucose conditions[J]. J Diabetes Res,2013,2013:979702.
周雪梅,徐从书,王凯,等.益气养阴活血中药对糖尿病肾病大鼠Notch/Hes1通路与血管内皮CD34、CD144的影响[J].南方医科大学学报,2019,39(7):855-860.
刘利飞,李雅纯,国芳,等.Notch通路在糖尿病肾病大鼠的表达及化瘀通络中药的干预作用[J].中草药,2018,49(8):1866-1870.
江丹,汤海欣,姚楠,等.益气升清方对糖尿病肾病大鼠Notch信号通路的影响机制研究[J].按摩与康复医学,2019,10(14):48-51.
姜甫昇.榛花消肾安胶囊干预实验性糖尿病大鼠足细胞转分化notch通路研究[D].长春:长春中医药大学,2017.
周禹含.Notch通路在糖尿病大鼠肾小球表达及解毒通络保肾胶囊对其影响研究[D].长春:长春中医药大学,2015.
杨冠男,赵宗江,张新雪,等.糖肾宁对糖尿病肾病KKAy小鼠的肾脏保护作用及其对Notch/Snail1信号转导通路的影响[J].世界科学技术—中医药现代化,2017,19(6):1057-1065.
韩菲.雷公藤甲素通过PDK1/Akt及miR-137/Notch1通路改善糖尿病肾病的机制研究[D].天津:天津医科大学,2018.
邓文荣,石文清,李海俏,等.姜黄素对糖尿病肾病大鼠肾功能及肾组织JNK、Notch2/hes1信号通路的影响[J].山东医药,2020,60(14):5-8.
张洁,韩丽红,王彩丽.Notch信号通路在IgA肾病中的表达[J].当代医学,2019,25(29):1-5.
王军,李良志,谭琴兰,等.Notch信号通路在IgA肾病肾间质纤维化中的表达和意义[J].中国中西医结合肾病杂志,2019,20(2):117-120.
赵建明,朱小华.基于Notch信号通路探讨黄葵总黄酮对IgA肾病大鼠的治疗作用机制研究[J].中国中西医结合肾病杂志,2018,19(11):969-971.
刘丹,王彩丽.雷公藤红素对IgA肾病大鼠肾脏组织中Notch信号通路表达的影响研究[J].重庆医学,2016,45(25):3457-3461.
王媛媛. Notch信号调控髓系细胞参与肾纤维化的机制研究[D].西安:第四军医大学,2016.
杜轩,涂卫平.Notch通路及维甲酸与肾纤维化研究进展[J].天津医药,2014,42(9):956-960.
DJUDJAJ S,CHATZIANTONIOU C,RAFFETSEDER U,et al. Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury[J]. J Pathol,2012,228(3):286-299.
隆献,黄勇攀,周言,等.基于析因设计探讨六味地黄汤不同组方对5/6肾切除大鼠肾纤维化的影响[J].中国中医药现代远程教育,2021,19(3):149-151.
黄仁发,梁群卿,黄国东,等.加味六味地黄汤对单侧输尿管梗阻大鼠肾组织Notch1/jagged1信号通路的影响[J].中国中医基础医学杂志,2015,21(11):1401-1403.
陈莹莹.大黄附子汤不同比例配伍对UUO模型大鼠的作用及机理研究[D].哈尔滨:黑龙江中医药大学,2020.
汪国敏,李丽燕,吴小燕,等.清化固肾排毒方对单侧输尿管梗阻大鼠肾组织Notch1和Jagged1表达的影响[J].上海中医药杂志,2017,51(9):104-108.
莫陶然,贠捷,盛紫阳,等.虫草益肾方对单侧输尿管梗阻大鼠Notch信号通路的影响[J].四川中医,2019,37(6):39-43.
钟建,赵宁博,刘朝业,等.益肾活血方通过miR-126/VEGF-Notch信号通路改善肾纤维化[J].中华危重病急救医学,2018,30(10):991-995.
陈莎莎.丹参酮ⅡA联合DAPT对TGF-β1诱导的人肾小管上皮细胞转分化过程中Notch1/Jagged1信号通路的影响[D].遵义:遵义医科大学,2020.
冯定浩,李均,徐静雅,等.丹参酮ⅡA联合DAPT对UUO模型大鼠肾组织Notch/Jagged通路相关蛋白表达的影响[J].中国中西医结合杂志,2019,39(7):826-831.
谭禹洁,朱春玲,毛华雄.黄芩苷对单侧输尿管梗阻肾间质纤维化大鼠模型的治疗作用及机制研究[J].中国当代儿科杂志,2016,18(4):365-371.
祖宁辉,施田力,黄小惠,等.姜黄素对单侧输尿管梗阻大鼠肾纤维化的影响[J].中国临床药理学杂志,2020,36(10):1277-1279.
邹海波,孙晓峰.姜黄素后处理对缺血再灌注肾损伤大鼠Notch2/Hes1通路的影响[J].中国现代医学杂志,2019,29(19):17-22.
高飞,王泽泽,杨冰,等.加味升降散对膜性肾病大鼠Notch信号通路及足细胞凋亡的影响[J].中国实验方剂学杂志,2021,27(4):30-36.
尚懿纯,曹式丽,杨洪涛,等.肾苏Ⅱ方对局灶节段性肾小球硬化大鼠Notch-P53通路及足细胞凋亡的影响[J].中国中西医结合杂志,2017,37(8):973-978.
尚懿纯,曹式丽,杨洪涛,等.肾苏Ⅱ方对局灶节段性肾小球硬化大鼠Notch-PI3K/PKB通路串话及足细胞EMT的影响[J].中华中医药杂志,2016,31(12):5271-5276.
方欢,王鹏,王毅东,等.益气解毒方药物血清对人肾细胞癌ACHN细胞凋亡及Notch1基因的影响[J].肿瘤研究与临床,2019,31(7):446-451.
高宇.软坚散结胶囊通过Notch和PI3K/Akt信号通路诱导肾癌细胞凋亡及其分子机制的研究[D].北京:北京中医药大学,2015.
朱丽华,熊御云,夏琳,等.积雪草酸预处理对脓毒症小鼠急性肾损伤的影响及机制[J].山东医药,2017,57(30):10-13.
黄仁发,梁群卿,程新,等.发酵虫草菌粉和泼尼松对急性马兜铃酸肾病大鼠肾小管Notch2/hes1信号通路活化的影响[J].中国中西医结合杂志,2013,33(8):1116-1121.
黄飞,刘成福,王小琴.金匮肾气丸对庆大霉素诱导肾损伤大鼠肾组织Notch2/hes1信号通路的影响[J].中国中西医结合肾病杂志,2013,14(1):29-32.
王英明,冯月阳,程建林,等.慢性肾脏病临床特征及中医治疗思路探讨[J].中医药临床杂志,2021,33(4):601-604.
谢永祥,龙春莉,钟建,等.慢性肾脏病分期辨治的探讨[J].现代中西医结合杂志,2011,20(17):2154-2155.
0
Views
10
下载量
3
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution